Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1559 studies found for:    "Squamous cell carcinoma"
Show Display Options
RSS Create an RSS feed from your search for:
"Squamous cell carcinoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients
Condition: Squamous Cell Carcinoma
Intervention:
2 Unknown  Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Interventions: Drug: Nedaplatin;   Drug: Cisplatin;   Drug: Docetaxel
3 Not yet recruiting PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck;   Squamous Cell Carcinoma
Interventions: Drug: Pembrolizumab;   Radiation: Radiotherapy;   Drug: Chemotherapy
4 Completed
Has Results
Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
Condition: Squamous Cell Carcinoma
Intervention: Drug: Erlotinib
5 Active, not recruiting Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx
Condition: Squamous Cell Carcinoma of Oropharynx
Interventions: Radiation: IMRT;   Drug: Cisplatin;   Drug: Carboplatin
6 Active, not recruiting Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Interventions: Drug: Nimotuzumab;   Drug: Placebo;   Drug: cisplatin;   Radiation: Radiotherapy
7 Terminated
Has Results
Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Interventions: Drug: Erlotinib;   Drug: Temsirolimus
8 Recruiting A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya
Condition: Esophageal Squamous Cell Carcinoma
Intervention:
9 Not yet recruiting Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
Condition: Penile Squamous Cell Carcinoma
Intervention: Drug: Pembrolizumab
10 Recruiting Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell Carcinoma
Condition: Esophageal Squamous Cell Carcinoma
Interventions: Drug: Apatinib;   Drug: Irinotecan
11 Recruiting Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma
Condition: Esophageal Squamous Cell Carcinoma
Interventions: Drug: Nimotuzumab;   Drug: Paclitaxel;   Drug: Cisplatin;   Radiation: Radiation;   Procedure: Surgery
12 Completed Efficacy of AFL-assisted PDT in Microinvasive Squamous Cell Carcinoma
Condition: Microinvasive Squamous Cell Carcinoma
Interventions: Drug: lidocaine-prilocaine 5% cream application;   Device: 2940-nm Er:YAG AFL pretreatment;   Drug: methyl-aminolevulinate application;   Device: Illuminating using red light-emitting diode lamps
13 Unknown  Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck
Condition: Squamous Cell Carcinoma of Head and Neck
Intervention: Drug: Pemetrexed
14 Completed
Has Results
Warning Signs of Squamous Cell Carcinoma and Prevention of SCC by at Risk Organ Transplant Recipients
Condition: Squamous Cell Carcinoma
Interventions: Behavioral: Educational Intervention;   Behavioral: Placebo
15 Active, not recruiting Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx
Condition: Squamous Cell Carcinoma
Interventions: Drug: fluorine F18 EF5;   Procedure: immunohistochemistry staining method;   Procedure: biopsy;   Procedure: Positron Emission tomography
16 Recruiting Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma
Condition: Esophageal Squamous Cell Carcinoma Resectable
Intervention: Drug: Nimotuzumab combined with paclitaxel and cisplatin
17 Completed Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma
Condition: Metastatic Esophageal Squamous Cell Carcinoma
Intervention:
18 Recruiting Survival Benefit of Elective Neck Dissection in T1,2N0M0 Oral Squamous Cell Carcinoma
Condition: Oral Squamous Cell Carcinoma
Intervention: Procedure: elective neck dissection
19 Recruiting Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Drug: 18-F FDG
20 Terminated
Has Results
Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: afatinib;   Other: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.